Annual Non Current Assets
$26.77 B
-$4.22 B-13.61%
December 31, 2024
Summary
- As of February 25, 2025, TEVA annual long term assets is $26.77 billion, with the most recent change of -$4.22 billion (-13.61%) on December 31, 2024.
- During the last 3 years, TEVA annual non current assets has fallen by -$8.32 billion (-23.71%).
- TEVA annual non current assets is now -64.69% below its all-time high of $75.83 billion, reached on December 31, 2016.
Performance
TEVA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$26.77 B
-$2.67 B-9.07%
December 31, 2024
Summary
- As of February 25, 2025, TEVA quarterly long term assets is $26.77 billion, with the most recent change of -$2.67 billion (-9.07%) on December 31, 2024.
- Over the past year, TEVA quarterly non current assets has stayed the same.
- TEVA quarterly non current assets is now -67.09% below its all-time high of $81.36 billion, reached on September 30, 2016.
Performance
TEVA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
TEVA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | 0.0% |
| 3 y3 years | -23.7% | 0.0% |
| 5 y5 years | -39.2% | 0.0% |
TEVA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.7% | at low | -23.7% | at low |
| 5 y | 5-year | -39.2% | at low | -39.2% | at low |
| alltime | all time | -64.7% | >+9999.0% | -67.1% | >+9999.0% |
Teva Pharmaceutical Industries Limited Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $12.55 B(+0.5%) | $26.77 B(-9.1%) |
| Sep 2024 | - | $29.45 B(-0.9%) |
| Jun 2024 | - | $29.71 B(-2.5%) |
| Mar 2024 | - | $30.48 B(-1.7%) |
| Dec 2023 | $12.48 B(+3.6%) | $30.99 B(+1.1%) |
| Sep 2023 | - | $30.66 B(-1.1%) |
| Jun 2023 | - | $31.01 B(-3.0%) |
| Mar 2023 | - | $31.96 B(-0.0%) |
| Dec 2022 | $12.05 B(-4.2%) | $31.96 B(-2.6%) |
| Sep 2022 | - | $32.80 B(-2.9%) |
| Jun 2022 | - | $33.77 B(-2.4%) |
| Mar 2022 | - | $34.61 B(-1.4%) |
| Dec 2021 | $12.57 B(-3.3%) | $35.09 B(-1.7%) |
| Sep 2021 | - | $35.70 B(-1.9%) |
| Jun 2021 | - | $36.37 B(-0.6%) |
| Mar 2021 | - | $36.60 B(-2.7%) |
| Dec 2020 | $13.01 B(-3.4%) | $37.63 B(+0.2%) |
| Sep 2020 | - | $37.58 B(-11.0%) |
| Jun 2020 | - | $42.21 B(-0.6%) |
| Mar 2020 | - | $42.45 B(-3.5%) |
| Dec 2019 | $13.46 B(-2.4%) | $44.01 B(-1.6%) |
| Sep 2019 | - | $44.70 B(-2.0%) |
| Jun 2019 | - | $45.62 B(-1.7%) |
| Mar 2019 | - | $46.42 B(-1.0%) |
| Dec 2018 | $13.79 B(-10.3%) | $46.89 B(-8.4%) |
| Sep 2018 | - | $51.18 B(-2.2%) |
| Jun 2018 | - | $52.32 B(-4.0%) |
| Mar 2018 | - | $54.49 B(-1.3%) |
| Dec 2017 | $15.38 B(-10.7%) | $55.23 B(-20.9%) |
| Sep 2017 | - | $69.86 B(-2.7%) |
| Jun 2017 | - | $71.76 B(-6.1%) |
| Mar 2017 | - | $76.44 B(+0.8%) |
| Dec 2016 | $17.23 B(-6.4%) | $75.83 B(-6.8%) |
| Sep 2016 | - | $81.36 B(+105.6%) |
| Jun 2016 | - | $39.58 B(+3.8%) |
| Mar 2016 | - | $38.13 B(+6.4%) |
| Dec 2015 | $18.40 B(+27.8%) | $35.84 B(-0.8%) |
| Sep 2015 | - | $36.13 B(-2.6%) |
| Jun 2015 | - | $37.07 B(+18.7%) |
| Mar 2015 | - | $31.24 B(-2.4%) |
| Dec 2014 | $14.40 B(+4.9%) | $32.02 B(-2.0%) |
| Sep 2014 | - | $32.69 B(-1.5%) |
| Jun 2014 | - | $33.19 B(-0.8%) |
| Mar 2014 | - | $33.44 B(-1.0%) |
| Dec 2013 | $13.72 B(-16.1%) | $33.79 B(-0.5%) |
| Sep 2013 | - | $33.94 B(+1.6%) |
| Jun 2013 | - | $33.41 B(-0.7%) |
| Mar 2013 | - | $33.65 B(-1.8%) |
| Dec 2012 | $16.36 B(+13.2%) | $34.25 B(-1.0%) |
| Sep 2012 | - | $34.60 B(-0.2%) |
| Jun 2012 | - | $34.66 B(-2.4%) |
| Mar 2012 | - | $35.50 B(-0.5%) |
| Dec 2011 | $14.45 B(+20.0%) | $35.69 B(+26.3%) |
| Sep 2011 | - | $28.26 B(+2.5%) |
| Jun 2011 | - | $27.56 B(+1.3%) |
| Mar 2011 | - | $27.20 B(+4.2%) |
| Dec 2010 | $12.04 B(+0.0%) | $26.11 B(-3.9%) |
| Sep 2010 | - | $27.18 B(+31.0%) |
| Jun 2010 | - | $20.74 B(-3.3%) |
| Mar 2010 | - | $21.44 B(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $12.04 B(+5.4%) | $21.17 B(-3.1%) |
| Sep 2009 | - | $21.84 B(+2.9%) |
| Jun 2009 | - | $21.22 B(+0.5%) |
| Mar 2009 | - | $21.10 B(-1.7%) |
| Dec 2008 | $11.43 B(+15.9%) | $21.48 B(+53.2%) |
| Sep 2008 | - | $14.02 B(-1.3%) |
| Jun 2008 | - | $14.20 B(+0.4%) |
| Mar 2008 | - | $14.14 B(+4.3%) |
| Dec 2007 | $9.86 B(+29.0%) | $13.55 B(+1.4%) |
| Sep 2007 | - | $13.36 B(+2.2%) |
| Jun 2007 | - | $13.07 B(+0.5%) |
| Mar 2007 | - | $13.01 B(+1.4%) |
| Dec 2006 | $7.64 B(+38.8%) | $12.83 B(+0.5%) |
| Sep 2006 | - | $12.76 B(+0.5%) |
| Jun 2006 | - | $12.70 B(+1.6%) |
| Mar 2006 | - | $12.50 B(+156.1%) |
| Dec 2005 | $5.50 B(+31.0%) | $4.88 B(-7.3%) |
| Sep 2005 | - | $5.27 B(+1.8%) |
| Jun 2005 | - | $5.17 B(-1.9%) |
| Mar 2005 | - | $5.27 B(-2.9%) |
| Dec 2004 | $4.20 B(+13.1%) | $5.43 B(+9.9%) |
| Sep 2004 | - | $4.94 B(+0.4%) |
| Jun 2004 | - | $4.92 B(+2.0%) |
| Mar 2004 | - | $4.83 B(+119.4%) |
| Dec 2003 | $3.72 B(+28.1%) | $2.20 B(+0.7%) |
| Sep 2003 | - | $2.18 B(+7.6%) |
| Jun 2003 | - | $2.03 B(+11.2%) |
| Mar 2003 | - | $1.83 B(+5.9%) |
| Dec 2002 | $2.90 B(+33.2%) | $1.73 B(+1.4%) |
| Sep 2002 | - | $1.70 B(+3.3%) |
| Jun 2002 | - | $1.65 B(+13.5%) |
| Mar 2002 | - | $1.45 B(+13.2%) |
| Dec 2001 | $2.18 B(+35.4%) | $1.28 B(+2.0%) |
| Sep 2001 | - | $1.26 B(+1.6%) |
| Jun 2001 | - | $1.24 B(+1.3%) |
| Mar 2001 | - | $1.22 B(-2.1%) |
| Dec 2000 | $1.61 B(+75.2%) | $1.25 B(+8.2%) |
| Sep 2000 | - | $1.15 B(-2.9%) |
| Jun 2000 | - | $1.19 B(+47.5%) |
| Mar 2000 | - | $803.87 M(-4.0%) |
| Dec 1999 | $918.03 M(+18.3%) | $837.25 M(+5.2%) |
| Sep 1999 | - | $795.80 M(+23.9%) |
| Jun 1999 | - | $642.20 M(-0.5%) |
| Mar 1999 | - | $645.50 M(-2.2%) |
| Dec 1998 | $776.20 M(+16.1%) | $659.80 M(-1.5%) |
| Sep 1998 | - | $670.10 M(+9.4%) |
| Jun 1998 | - | $612.70 M(+17.8%) |
| Mar 1998 | - | $520.20 M(+0.1%) |
| Dec 1997 | $668.80 M(-7.9%) | $519.60 M(+0.8%) |
| Dec 1996 | $725.90 M(+32.7%) | $515.50 M(+4.7%) |
| Dec 1995 | $547.00 M(+36.9%) | $492.40 M(+78.1%) |
| Dec 1994 | $399.60 M(+19.5%) | $276.40 M(+20.9%) |
| Dec 1993 | $334.30 M(+27.1%) | $228.70 M(+25.7%) |
| Dec 1992 | $263.00 M(+15.8%) | $182.00 M(+21.7%) |
| Dec 1991 | $227.20 M(+13.2%) | $149.50 M(+4.5%) |
| Dec 1990 | $200.70 M(+27.0%) | $143.10 M(+11.2%) |
| Dec 1989 | $158.00 M(+23.1%) | $128.70 M(+7.5%) |
| Dec 1988 | $128.40 M(+48.4%) | $119.70 M(+112.6%) |
| Mar 1987 | $86.50 M(+0.6%) | $56.30 M(+6.0%) |
| Mar 1986 | $86.00 M | $53.10 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual long term assets?
- What is the all time high annual non current assets for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual non current assets year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly long term assets?
- What is the all time high quarterly non current assets for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly non current assets year-on-year change?
What is Teva Pharmaceutical Industries Limited annual long term assets?
The current annual non current assets of TEVA is $26.77 B
What is the all time high annual non current assets for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual long term assets is $75.83 B
What is Teva Pharmaceutical Industries Limited annual non current assets year-on-year change?
Over the past year, TEVA annual long term assets has changed by -$4.22 B (-13.61%)
What is Teva Pharmaceutical Industries Limited quarterly long term assets?
The current quarterly non current assets of TEVA is $26.77 B
What is the all time high quarterly non current assets for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly long term assets is $81.36 B
What is Teva Pharmaceutical Industries Limited quarterly non current assets year-on-year change?
Over the past year, TEVA quarterly long term assets has changed by $0.00 (0.00%)